Administration, handling, and safety
This unit covers both administration and safety, and it does so without ever telling you to use MOTS-c.
How it is used in research, how it is marketed, and how thin the safety data really is
This unit covers both administration and safety, and it does so without ever telling you to use MOTS-c. In preclinical research it is typically given by intraperitoneal injection to mice. For the human side this unit uses one source and names it: FDA’s own 2026 survey of how MOTS-c is marketed, written for the advisory committee. That is a record of claims made by sellers, not a record of what anyone took or what it did.
On safety, the honest answer is blunter than "limited". FDA did not identify any clinical studies or human exposure data for MOTS-c by any route of administration, found no repeat-dose toxicity, genotoxicity, reproductive or carcinogenicity studies, and retrieved no adverse-event reports. That is not a thin dataset. It is an absent one. We will show the reconstitution arithmetic as education only and keep a not-medical-advice line throughout.